Mr. HOLT. Mr. Speaker, I rise in support of H.R. 1919, the Safeguarding America's Pharmaceuticals Act of 2013. Currently, there exists a patchwork of state regulations that provide for uneven detection of contaminated drugs and falsified medicines. Recognizing this, the Institutes of Medicine (IOM) recommend in a February 2013 report that ``Congress should authorize and fund the U.S. Food and Drug Administration (FDA) to establish a mandatory track-and trace system.'' The Safeguarding America's Pharmaceuticals Act of 2013 makes important progress in providing for a national standard of tracing medicines electronically through the supply chain. We should be doing all that we can to ensure the security and authenticity of all medicines in the United States. The enhanced drug distribution security required by this legislation provides manufacturers with important protections against counterfeit drugs as well as increases patient safety for American consumers.